Today: 11 June 2026
Silver price snaps back toward $90 after crash; traders brace for more swings
4 February 2026
2 mins read

Silver price snaps back toward $90 after crash; traders brace for more swings

NEW YORK, Feb 4, 2026, 10:05 (EST) — Regular session.

  • Spot silver rebounds nearly 6% to about $90 an ounce after last week’s rout
  • CME margin hikes and the Fed chair shake-up keep leverage on the run
  • Focus shifts to ECB and BoE decisions on Feb. 5, plus U.S. data disruptions

Silver climbed nearly 6% to around $90 an ounce on Wednesday as the metal extended a rebound from last week’s record slide. Spot gold was up 2% at $5,047 an ounce, holding above $5,000 after its sharp two-day jump. “We expect elevated volatility to continue in the near term, but stabilization should return once the market finds its footing,” said Joshua Chim, general manager at online broker FSMone. Reuters

The swing matters now because the market is still working through forced selling after CME Group lifted margin requirements — the cash collateral traders must post to hold futures positions. The selloff followed President Donald Trump’s announcement that Kevin Warsh would be his pick to lead the Federal Reserve, a choice investors saw as tilting policy toward a smaller Fed balance sheet and tighter financial conditions for non-yielding assets like precious metals.

Silver’s collapse also exposed how fast speculative money can turn. The metal hit an all-time high of $121.6 on Jan. 29, then shed more than a quarter of its value the next day as technical selling and stop-loss orders fed on each other. “There’s been a massive, massive retail frenzy getting into these markets,” said Saxo Bank commodity strategist Ole Hansen, who said the search for a floor hinges on China demand and calmer trading. Reuters

On Monday, trading remained choppy after Friday’s 27% rout, with silver last down 5.56% at $79.92 an ounce after earlier sliding as low as $71.33. Dealers said pressure on a number of silver futures funds in China added to the rout late last week, and the selling intensified after CME raised margins across several precious-metal contracts.

Volatility stayed at the center of the story. Ten-day realized volatility in silver hit 186% on Friday, according to Pepperstone strategist Chris Weston. Realized volatility is a backward-looking measure of how big the day-to-day moves have been, and it underscores why liquidity can vanish quickly when positions are leveraged.

But the rebound is fragile. Some analysts have argued a more fundamentally supported silver price sits in the $60–$70 range, with technical support near $66 using Fibonacci levels — a common chart-based method for gauging support and resistance. “There’s not much I can add to my warnings about how silver is always a death trap,” StoneX analyst Rhona O’Connell said. MarketScreener UAE Emirates

The slump has already rippled beyond trading desks. Shares of Danish jeweller Pandora jumped as much as 10% on Monday as the plunge in silver eased concerns about raw-material costs, with Jyske Bank analyst Janne Vincent Kjaer citing the spike in silver prices as a key market worry in recent months. Pandora is due to report fourth-quarter earnings on Feb. 5.

Traders also have central banks on the calendar. The ECB’s Governing Council wraps up its monetary policy meeting on Thursday, Feb. 5, followed by a press conference, and the Bank of England is due to publish its policy summary and minutes at midday London time the same day.

In the United States, the usual macro signposts are less clear. The Labor Department’s monthly employment report for January was pulled from Friday’s schedule during the brief federal shutdown, and officials have not set a new publication date.

A weaker-than-expected ADP report showed U.S. private payrolls rose by 22,000 in January, though markets barely reacted and economists often treat the series as a noisy guide to government data. The bigger issue for rates traders is when the official jobs report reappears — and whether gaps in data flow keep volatility in currencies, yields and metals elevated.

For silver, the next tests are simple: can it hold above $90 without another round of margin-driven selling, and do central banks and delayed U.S. data keep safe-haven flows in play. Markets will be watching the ECB press conference and the BoE decision on Thursday, Feb. 5, along with any update on the rescheduled U.S. jobs report.

Stock Market Today

  • Jobless Claims Hit 4½-Month High Despite Stable Layoffs
    June 11, 2026, 11:14 AM EDT. Jobless claims in the U.S. rose to a 4½-month high in early June, signaling more individuals accessing unemployment benefits. However, this increase does not reflect a surge in layoffs, suggesting businesses are not cutting more jobs even as claims tick up. The data indicates a complex labor market where claims may rise for reasons other than widespread job losses.

Latest articles

Theriva Biologics Pops on VCN-01 Study Results, Gets Traders’ Attention

Theriva Biologics Pops on VCN-01 Study Results, Gets Traders’ Attention

11 June 2026
TOVX soared 74.6% to $0.4252 after Theriva Biologics published Phase 1 VCN-01 data showing survival and biomarker signals in head-and-neck cancer, but the jump was not due to drug approval or revenue; investors face ongoing financing, dilution, and clinical-trial execution risks, with the company’s cash runway only into Q1 2027 and substantial doubt about its ability to continue as a going concern without new capital.
Trulieve Stock Turns Heads on NYSE After $50 Million Buyback

Trulieve Stock Turns Heads on NYSE After $50 Million Buyback

11 June 2026
Trulieve began NYSE trading as TRLV this week after moving from OTC/CSE, authorized a buyback of up to $50 million or 8.5 million shares, and closed its first NYSE session at $11.50, down 0.43%, before trading near $11.78 early Thursday, as investors weigh whether the uplisting and buyback will boost demand amid ongoing federal cannabis policy uncertainty.
Propanc Biopharma Jumps on $5 Million Buyback Plan, Investors React

Propanc Biopharma Jumps on $5 Million Buyback Plan, Investors React

11 June 2026
Propanc Biopharma shares soared as much as 392% after authorizing up to $5 million in stock buybacks—exceeding its prior $3.1 million equity value—even as it reported just $443,702 in cash and flagged going-concern risks, with investors now focused on whether its lead cancer drug PRP will advance to a planned Phase 1b trial this year.
Take-Two (TTWO) stock eyes a sharp open after forecast raise, GTA VI date held
Previous Story

Take-Two (TTWO) stock eyes a sharp open after forecast raise, GTA VI date held

Apple stock jumps as Goldman flags App Store spending pickup, keeping AAPL in focus
Next Story

Apple stock jumps as Goldman flags App Store spending pickup, keeping AAPL in focus

Go toTop